Ajay Kumar: Created a new article

2023-08-09T07:29:11Z

Created a new article

New page

'''Dilip Girdharlal Shah,''' commonly known as DG Shah, was a pharmaceutical executive who founded the [[Indian Pharmaceutical Alliance]]. Shah was a member of the first batch of the [[Indian Institute of Management Ahmedabad|Indian Institute of Management, Ahmedabad]] (IIMA), which graduated in 1966.<ref name=":2">{{Cite web |last=Admin |first=D2C |title=Meet the ‘Shahs’ - The First Family to graduate from IIM Ahmedabad // Unstop (formerly Dare2Compete) |url=https://unstop.com/blog/meet-the-shahs-the-first-family-of-iim-ahmedabad |access-date=2023-08-05 |website=unstop.com |language=en}}</ref> At IIMA, Shah met Smita Dalal, whom he eventually married. They are considered to be the first couple in the history of IIMA.<ref name=":2" /> Upon graduation, Shah started worked for [[Pfizer]] in 1967. He worked for Pfizer for 30 years as a Commercial Director<ref name=":0">{{Cite web |title=IPA Founder DG Shah passes away |url=https://www.biospectrumindia.com/news/66/12907/ipa-founder-dg-shah-passes-away.html |access-date=2023-08-05 |website=www.biospectrumindia.com |language=en}}</ref> and eventually became a member of the board of directors for Pfizer-India.

In 1999, Shah founded the [[Indian Pharmaceutical Alliance]] (IPA) to promote the cause of generic drugs in India and to oppose the drug intellectual property rights defined by the [[TRIPS Agreement]]. Divya Rajgopal, writing for [[The Economic Times]], notes that:<ref>{{Cite news |last=Rajagopal |first=Divya |date=2019-02-22 |title=D G Shah founder of Indian Pharmaceutical Alliance dies at age 77 |work=The Economic Times |url=https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/d-g-shah-founder-of-indian-pharmaceutical-alliance-dies-at-age-77/articleshow/68107459.cms?from=mdr |access-date=2023-08-05 |issn=0013-0389}}</ref><blockquote>Shah and the IPA became the body that resisted the Intellectual Property Rights that lower income countries like India were forced to sign under the World Trade Organisation's TRIPS agreement. The IPA positioned itself as the voice of generic drug companies that claimed to represent the interests of Indian drug companies who were bullied under these TRIPS agreement. Shah, few pharma industry veterans recall was at times even more powerful than the Indian CEO's whose interests he represented to the bureaucrats and ministers in Delhi.</blockquote>With the IPA, Shah helped Indian companies communicate with the [[Food and Drug Administration|US Food and Drug Administration]] (USFDA) and contributed "in the shaping of the current Indian patent law, which favours affordable medicines, while also recognising the obligations under the TRIPS agreement".<ref>{{Cite web |date=2019-02-22 |title=Indian generic industry loses a titan in DG Shah |url=https://www.businesstoday.in/opinion/alchemy/story/indian-generic-industry-loses-a-titan-in-dg-shah-172758-2019-02-22 |access-date=2023-08-05 |website=Business Today |language=en}}</ref> Shah was a member of the official Indian delegation for the [[World Trade Organization]] (WTO) ministerial conference at Cancun and testified on behalf of India in an appearance before the [[United States International Trade Commission]] (USITC).<ref name=":1">{{Cite web |date=2019-02-22 |title=Pharma veteran DG Shah passed away |url=https://www.businesstoday.in/industry/pharma/story/pharma-veteran-dg-shah-passed-away-172924-2019-02-22 |access-date=2023-08-05 |website=Business Today |language=en}}</ref> He also was the author of the first book on drug pricing in India.<ref name=":0" />

Apart from his work with the IPA, Shah set up a company called Vision Consulting Group to consult about matters of public policy, strategy, and planning<ref name=":0" /> and served in a variety of advisory roles. He was the Chair of the International Generic Pharmaceutical Alliance (IGPA) for two terms in 2005-07 and 2010-11,<ref name=":1" /> a Non-Executive Independent Director of Fresenius Kabi Oncology Limited (formerly Dabur Pharma Limited), an Independent Non-Executive Director at Anuh Pharma Ltd. (October 2007-February 2019), a member of the advisory panel for PharmaGenerics UK, an Additional Director of Lyka Labs Ltd. (from July 2008 to April 2009), an editor for the [[Journal of Generic Medicines|Journal of Generics Medicines]], and a guest faculty for the Management Development Programmes at his alma mater IIMA.<ref name=":0" />

Shah died on February 22, 2019.<ref>{{Cite web |date=2019-02-22 |title=DG Shah: Indian pharma loses a significant voice on international trade and policy |url=https://www.thehindubusinessline.com/news/dg-shah-indian-pharma-loses-a-significant-voice-on-international-trade-and-policy/article26342782.ece |access-date=2023-08-05 |website=www.thehindubusinessline.com |language=en}}</ref> The "DG Shah Award for best Public Policy Paper" at IIMA was posthumously established in his name.<ref>{{Cite web |title=IP Alliance institutes ‘DG Shah Award for best Public Policy Paper’ at IIM Ahmedabad |url=http://pharmabiz.com/newsdetails.aspx?aid=119676&sid=1 |access-date=2023-08-05 |website=pharmabiz.com}}</ref>

== References ==
{{Reflist}}

[[Category:Indian Institute of Management Ahmedabad alumni]]
[[Category:Indian businesspeople in the pharmaceutical industry]]
[[Category:Businesspeople from Mumbai]]
[[Category:2019 deaths]]

Dilip G Shah - Revision history

Ajay Kumar: Created a new article